Five-year outcomes of CD19 followed by CD22 chimeric antigen receptor T-cell therapy in B-cell acute lymphoblastic leukemia patients who relapsed after allo-transplantation

Affiliations

• ¹ Department of Hematology, Beijing Gobroad Boren Hospital, Beijing. [email protected].
• ² Department of Hematology, Beijing Gobroad Boren Hospital, Beijing.
• ³ Cytology Laboratory, Beijing Gobroad Boren Hospital, Beijing.
• ⁴ Medical Laboratory, Beijing Gobroad Boren Hospital, Beijing.
• ⁵ Department of Bone Marrow Transplantation, Beijing Gobroad Boren Hospital, Beijing.
• ⁶ Shanghai YaKe Biotechnology Ltd., Shanghai.
• ⁷ Department of Hematology, Beijing Gobroad Boren Hospital, Beijing. [email protected].